Obesity, Second Stage Duration, and Labor Outcomes in Nulliparous Women.


Journal

American journal of perinatology
ISSN: 1098-8785
Titre abrégé: Am J Perinatol
Pays: United States
ID NLM: 8405212

Informations de publication

Date de publication:
03 2021
Historique:
pubmed: 29 9 2019
medline: 5 11 2021
entrez: 29 9 2019
Statut: ppublish

Résumé

This study aimed to estimate second stage duration and its effects on labor outcomes in obese versus nonobese nulliparous women. This was a secondary analysis of a cohort of nulliparous women who presented for labor at term and reached complete cervical dilation. Adjusted relative risks (aRR) were used to estimate the association between obesity and second stage characteristics, composite neonatal morbidity, and composite maternal morbidity. Effect modification of prolonged second stage on the association between obesity and morbidity was assessed by including an interaction term in the regression model. Compared with nonobese, obese women were more likely to have a prolonged second stage (aRR: 1.48, 95% CI: 1.18-1.85 for ≥3 hours; aRR: 1.65, 95% CI: 1.18-2.30 for ≥4 hours). Obesity was associated with a higher rate of second stage cesarean (aRR: 1.78, 95% CI: 1.34-2.34) and cesarean delivery for fetal distress (aRR: 2.67, 95% CI: 1.18-3.58). Obesity was also associated with increased rates of neonatal (aRR: 1.38, 95% CI: 1.05-1.80), but not maternal morbidity (aRR: 1.06, 95% CI: 0.90-1.25). Neonatal morbidity risk was not modified by prolonged second stage. Obesity is associated with increased risk of neonatal morbidity, which is not modified by prolonged second stage of labor.

Identifiants

pubmed: 31563134
doi: 10.1055/s-0039-1697586
pmc: PMC8081034
mid: NIHMS1627101
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

342-349

Subventions

Organisme : NICHD NIH HHS
ID : K12 HD063086
Pays : United States
Organisme : NICHD NIH HHS
ID : K23 HD098315
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK056341
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD061619
Pays : United States

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

None declared.

Références

Arch Gynecol Obstet. 2008 Sep;278(3):245-9
pubmed: 18189142
Arch Gynecol Obstet. 2008 Dec;278(6):547-53
pubmed: 18379807
Obstet Gynecol. 2004 Mar;103(3):452-6
pubmed: 14990405
Obstet Gynecol. 2014 Mar;123(3):693-711
pubmed: 24553167
Eur J Obstet Gynecol Reprod Biol. 2014 Nov;182:43-7
pubmed: 25218551
Obstet Gynecol. 2016 Dec;128(6):e241-e256
pubmed: 27875472
BJOG. 2013 Jul;120(8):932-9
pubmed: 23530609
Clin Sci (Lond). 2016 Feb;130(3):183-92
pubmed: 26543049
JAMA. 1998 Nov 18;280(19):1690-1
pubmed: 9832001
Am J Obstet Gynecol. 2009 Oct;201(4):357.e1-7
pubmed: 19788967
Am J Obstet Gynecol. 2004 Sep;191(3):933-8
pubmed: 15467567
Eur J Obstet Gynecol Reprod Biol. 2005 Jan 10;118(1):17-20
pubmed: 15596266
Obstet Gynecol. 2011 Dec;118(6):1309-1313
pubmed: 22105260
Am J Obstet Gynecol. 2004 Apr;190(4):1091-7
pubmed: 15118648
Obstet Gynecol. 2017 Aug;130(2):e95-e101
pubmed: 28742677
BJOG. 2005 Jun;112(6):768-72
pubmed: 15924535
Am J Obstet Gynecol. 2011 Sep;205(3):244.e1-8
pubmed: 21798510
JAMA. 2016 Jun 7;315(21):2284-91
pubmed: 27272580
Obstet Gynecol. 2012 Jul;120(1):130-5
pubmed: 22914401
Int J Obes Relat Metab Disord. 2001 Aug;25(8):1175-82
pubmed: 11477502
Obes Rev. 2008 Nov;9(6):635-83
pubmed: 18673307
BJOG. 2007 Mar;114(3):343-8
pubmed: 17261121
Am J Obstet Gynecol. 2016 Apr;214(4):484-489
pubmed: 26546847
J Midwifery Womens Health. 2000 Jan-Feb;45(1):67-71
pubmed: 10772737
Obstet Gynecol. 2011 Jun;117(6):1315-1322
pubmed: 21606741
Pregnancy Hypertens. 2017 Oct;10:57-63
pubmed: 29153691
Am J Obstet Gynecol. 2014 Oct;211(4):410.e1-6
pubmed: 24657794
Am J Obstet Gynecol. 2009 Oct;201(4):361.e1-7
pubmed: 19788968
Am J Obstet Gynecol. 1991 Oct;165(4 Pt 1):976-9
pubmed: 1951566
Am J Perinatol. 2012 Oct;29(9):717-22
pubmed: 22644830
J Matern Fetal Neonatal Med. 2019 Jan;32(1):92-94
pubmed: 28851241
Am J Obstet Gynecol. 2001 Oct;185(4):845-9
pubmed: 11641663
Obstet Gynecol. 2009 Jun;113(6):1248-1258
pubmed: 19461419
Am J Obstet Gynecol. 2013 Oct;209(4):386.e1-6
pubmed: 23727523
J Matern Fetal Neonatal Med. 2017 Feb;30(4):461-465
pubmed: 27050812
J Matern Fetal Neonatal Med. 2015 May;28(7):829-35
pubmed: 24939628
Am J Perinatol. 2014 Apr;31(4):299-304
pubmed: 23765707
Obstet Gynecol. 2004 Nov;104(5 Pt 1):943-51
pubmed: 15516383

Auteurs

Antonina I Frolova (AI)

Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, Missouri.

Nandini Raghuraman (N)

Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, Missouri.

Molly J Stout (MJ)

Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, Missouri.

Methodius G Tuuli (MG)

Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, Missouri.
Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, Indiana.

George A Macones (GA)

Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, Missouri.

Alison G Cahill (AG)

Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, Missouri.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH